Total submissions: 13
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000667686 | SCV000792174 | pathogenic | Retinitis pigmentosa 28 | 2017-06-19 | criteria provided, single submitter | clinical testing | |
Eurofins Ntd Llc |
RCV000733055 | SCV000861074 | pathogenic | not provided | 2018-04-25 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000733055 | SCV001228083 | pathogenic | not provided | 2023-12-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys501Valfs*4) in the FAM161A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FAM161A are known to be pathogenic (PMID: 20705278, 20705279, 24651477). This variant is present in population databases (rs767414973, gnomAD 0.02%). This premature translational stop signal has been observed in individuals with retinitis pigmentosa or a retinal dystrophy (PMID: 23591405, 25097241, 26574802). ClinVar contains an entry for this variant (Variation ID: 552429). For these reasons, this variant has been classified as Pathogenic. |
Blueprint Genetics | RCV001073558 | SCV001239109 | pathogenic | Retinal dystrophy | 2019-06-16 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000733055 | SCV001246770 | pathogenic | not provided | 2017-05-01 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV000667686 | SCV003831198 | likely pathogenic | Retinitis pigmentosa 28 | 2022-03-30 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000667686 | SCV004195943 | pathogenic | Retinitis pigmentosa 28 | 2023-08-22 | criteria provided, single submitter | clinical testing | |
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000667686 | SCV000804652 | pathogenic | Retinitis pigmentosa 28 | 2016-09-01 | no assertion criteria provided | clinical testing | |
Department of Clinical Genetics, |
RCV000787605 | SCV000926589 | likely pathogenic | Retinitis pigmentosa | 2018-04-01 | no assertion criteria provided | research | |
Clinical Genetics, |
RCV000733055 | SCV001920389 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV000733055 | SCV001955058 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000733055 | SCV001980026 | pathogenic | not provided | no assertion criteria provided | clinical testing | ||
Natera, |
RCV000667686 | SCV002076601 | pathogenic | Retinitis pigmentosa 28 | 2020-08-03 | no assertion criteria provided | clinical testing |